Nasdaq GlobeNewswire

Align Technology Launches Treatment Planning Facility in Spain

Del

The newly opened facility will add 130 jobs in 2018, provide local support to Invisalign trained doctors in Spain and Portugal

MADRID, Spain and SAN JOSE, Calif., Sept. 07, 2018 (GLOBE NEWSWIRE) -- Align Technology, Inc. (NASDQ: ALGN), a global medical device company engaged in the design, manufacture and marketing of the Invisalign system and iTero intraoral scanners and services for orthodontic and restorative dentistry, announced today the launch of the new digital treatment planning facility and education centre in Madrid, Spain. The new launch reflects the dynamic growth of Spain and Portugal (jointly known as Iberia) in the EMEA region and beyond. Iberia is the third largest Invisalign market worldwide (after North America and China), growing dynamically year on year.

The second of its kind in Europe and the fourth worldwide, the treatment planning facility in Madrid aims to increase the company’s commitment to Invisalign trained doctors in Spain and Portugal, and will play a key role in Align Technology`s strategy to be closer to its customers and support them in digital treatment planning. The new facility, which will also act as education centre for doctors, will bring together current commercial teams representing Iberia and the new treatment planning team to provide Spanish and Portuguese doctors with first-hand support from the local staff. The new 3,500 square meter office will host 185 employees by the end of 2018 – a significant increase from the 10 employees employed in Spain since 2013.

“Since we launched our operations in the country 17 years ago, we have seen continuous growth and have played an important role in expanding Align’s operations in the EMEA region,” explained Juan Manuel Frade, Align Technology general manager, Iberia. “The city of Madrid offers a vibrant ecosystem for innovative companies, while our new facilities support Align`s efforts to offer first-hand local support to Spanish and Portuguese dental professionals, helping them achieve the clinical results they expect and deliver effective, cutting-edge dental options to their patients.”

The state-of-the-art facilities in Madrid will serve as commercial and operations site for the entire Iberia business. Align Technology, as a global medical company, works directly with doctors across both countries to provide them with the Invisalign system of clear aligners that doctors prescribe to their patients to straighten their teeth. The new facilities will provide Invisalign trained doctors with closer, more personalized support to ensure they in turn can offer improved service to their patients.

“Our newly opened facility in Madrid is an important step forward in bringing our technology closer to Invisalign doctors, in a time of growing demand for clear aligner therapy from both consumers and doctors,” said Emory Wright, senior vice president, global operations. This facility will allow us to directly support the orthodontists in Iberia in their effort to continue to achieve greater clinical outcomes in teeth straightening. The in-region expertise and localization of services in strategic markets is necessary for us to be able to serve the growing needs of the doctors for local support.”

The treatment planning facility will be equipped with the latest technology, including Align Technology’s proprietary software which makes it possible to create a customized treatment for each patient. The new treatment planning facilities are part of the 100 million dollar global investment that the company expects to make this year, and will enable the Madrid site to offer some of the most innovative orthodontic solutions in the region.

“We are extremely proud to be launching our second European treatment planning facility in Madrid. It spearheads the technological innovation within the clear aligner field, placing Spain and Portugal at the forefront of the digital future of orthodontics in Europe,” said Simon Beard, Align Technology senior vice president and managing director, EMEA. “Iberia continues dynamic business growth, being the strongest contributor to Align Technology’s 38% growth across EMEA last year. I am confident our expansion of the infrastructure and the geographical coverage will continue to deliver exceptional results and will help us strengthen our relations with Invisalign trained doctors in the region.”

The company officially opened the new facility today during a ceremony attended by Invisalign trained doctors from Spain, media and dental associations.

Clear aligners are a removable and transparent teeth-straightening solution produced using digital and 3D technologies. This type of solution differs from other orthodontic devices in that they are more comfortable and can be easily removed for eating or drinking. Used to treat minor to complex types of malocclusions, clear aligners are replaced every one or two weeks, depending on a doctor`s recommendation, gradually moving teeth towards the projected final position.

Digital treatments are created at Align Technology’s treatment planning facilities by CAD designers, following doctors’ guidelines and instructions. The new treatment planning facility represents a milestone in Align’s expansion in Iberia that will ensure that doctors in the region, which are already supported by local clinical and customer support teams, also benefit from the presence of local CAD designers, enabling doctors to offer an improved service to their own patients.

About Align Technology, Inc.

Align Technology is a global medical device company engaged in the design, manufacture and marketing the most advanced clear aligner system in the world and intraoral scanners and services for orthodontic and restorative dentistry. Align’s products help dental professionals achieve the clinical results they expect and deliver effective dental options to their patients. Visit www.aligntech.es or more information.

Media Contact:
Edelman
Oier Llinas
Oier.llinas@edelman.com
934881290

Karina Ludz
Align Technology
kludz@aligntech.com
+31 6211 434 20

Om Nasdaq GlobeNewswire

Nasdaq GlobeNewswire
Nasdaq GlobeNewswire
One Liberty Plaza - 165 Broadway
NY 10006 New York

+1 212 401 8700http://www.nasdaqomx.com

NASDAQ (NASDAQ: NDAQ) is a leading provider of trading, exchange technology, information and public company services across six continents.

Følg saker fra Nasdaq GlobeNewswire

Registrer deg med din epostadresse under for å få de nyeste sakene fra Nasdaq GlobeNewswire på epost fortløpende. Du kan melde deg av når som helst.

Siste saker fra Nasdaq GlobeNewswire

Service Providers Speed Deployment, Reduce Costs with Patton Cloud Edge Orchestration Service20.9.2018 22:16Pressemelding

Now, Telecom and UCaaS service providers can easily provision, manage, monitor, secure, alert, troubleshoot, analyze, and optimize services on the customer premise GAITHERSBURG, Md., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Patton Electronics—US-manufacturer of UC, cloud, and IoT-enabling solutions for carrier, enterprise, and industrial networks—has launched the new Patton Cloud service for carriers and service providers that deliver All-IP and hybrid voice-and-data services to business subscribers. Patton Cloud delivers a low-cost, easy-to-use, web-based edge-orchestration service that delivers a superior user experience. It offers remote touchless provisioning, monitoring, and troubleshooting—as well as security and alerting tools that reduce service turn-up costs, trouble tickets, and subscriber attrition. The Patton Cloud service offers quality-control mechanisms including pro-active monitoring and troubleshooting—combined with feature-license distribution pools for managing value-added

Inspirata Promotes Top Executives to Expanded Roles in Digital Pathology20.9.2018 21:12Pressemelding

Inspirata Founder and Executive Vice President, Mark Lloyd, is taking on an expanded role overseeing product management, and Inspirata Senior Vice President, Andrew Chomos, has been appointed to General Manager, Digital Pathology, overseeing the Center of Excellence in Pittsburgh along with all North America sales and customer support efforts. Tampa, FL, Sept. 20, 2018 (GLOBE NEWSWIRE) -- Cancer informatics and digital pathology workflow solution provider Inspirata®, Inc. announced today that two of its executives have taken on expanded roles in the company. The two are Inspirata Executive Vice President and Founder, Mark Lloyd, and Senior Vice President and General Manager, Digital Pathology, Andrew Chomos. Dr. Lloyd has accepted the expansion of his role to include product management for Digital Pathology. He is former cancer researcher at both Lombardi Cancer and Moffitt Cancer Center and is Inspirata’s foremost subject matter expert and thought leader on digital pathology and image

Tetraphase Pharmaceuticals Announces Adoption of Commission Decision Granting Marketing Authorisation Approval in the European Union for XERAVA™ (eravacycline) for the Treatment of Complicated Intra-Abdominal Infections20.9.2018 19:08Pressemelding

– Broad Product Label for Treatment of Complicated Intra-Abdominal Infections – – Phased Commercial Launch Expected in the First Half of 2019 – WATERTOWN, Mass., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Tetraphase Pharmaceuticals, Inc. (NASDAQ:TTPH), a biopharmaceutical company focused on developing and commercializing novel antibiotics to treat life-threatening multidrug-resistant (MDR) infections, today announced that the European Commission (EC) has adopted the Decision granting marketing authorisation for XERAVA (eravacycline) for injection for the treatment of complicated intra-abdominal infections (cIAI) in adults in the European Union. In clinical trials, XERAVA was well-tolerated and achieved high clinical cure rates in patients with cIAI, demonstrating statistical non-inferiority to two widely used comparators – ertapenem and meropenem. “The European approval of XERAVA, right after our recently announced FDA approval, marks our second significant regulatory approval within one month

UPDATE— Taconic Biosciences Becomes the First Animal Model Provider on General Services Administration Contract Schedule20.9.2018 18:07Pressemelding

RENSSELAER, N.Y., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Taconic Biosciences, a global leader in providing genetically engineered rodent model solutions, announces a new relationship with Government Scientific Source (GSS). GSS is a leading dedicated distributor of laboratory equipment to federal, state, and local governments on contract with the GSA (General Services Administration). By having Taconic’s products available via GSS, they can now be accessed by all federal agencies, including but not limited to the National Institutes of Health and the Department of Defense. Taconic is the only animal model provider affiliated with GSS and the only animal model provider available on GSA Contract. “An important component of providing customers with the best animal model solutions is access to key resources. Through this exciting new relationship with GSS, Taconic can now easily connect with scientists doing some of the most valuable research in the world and provide them with high quality sol

Digital Transformation is Not a One-Off — It’s About the Digital Journey20.9.2018 17:44Pressemelding

SoftServe study confirms four digital journey states with 71 percent of enterprises reporting early stages of adoption AUSTIN, Texas, Sept. 20, 2018 (GLOBE NEWSWIRE) -- SoftServe, a leading digital authority and consulting company, today released the results of its market research study that examines how enterprises are responding to the digital economy. The research found that 71 percent of the respondents in the United States and the European Union are in the early stages—Reveal and Transform—of four unique states across the Enterprise Digital Journey. For an in-depth analysis and the full results, read The Enterprise Digital Journey white paper. With fierce competition in today’s global landscape, leveraging cutting-edge technology and deploying new business models is not a one-off pursuit, but rather a continuous process of iteration and refinement. Companies should stop referring to Digital Transformation and instead plan for a continuous Digital Journey. “The term Digital Transfo

Anomali Announces Major Expansion of Threat Platform Partner Ecosystem20.9.2018 16:00Pressemelding

New Developer SDKs enable partners to integrate solutions with Anomali Threat Platform NATIONAL HARBOR, Md., Sept. 20, 2018 (GLOBE NEWSWIRE) -- Anomali today announced at the Detect Conference 2018 the expansion of the partner ecosystem with the launch of a suite of partner developer resources. The new tools enable easier and faster integration with the Anomali Threat Platform and APP Store, allowing clients immediate access to partner content, integrations and analytics. The partner program expansion includes the launch of a suite of software development kits (SDKs). The SDKs address three critical integration areas: Threat Intelligence Feeds SDK: integrate proprietary threat intelligence feeds and make these accessible via the APP Store Integration SDK: integrate threat intelligence from the Anomali Threat Platform into third party products and solutions Enrichment SDK: integrate 3rd party threat analysis and data enrichments into the Anomali Threat Platform “Organizations need a com

I vårt presserom finner du alle våre siste saker, kontaktpersoner, bilder, dokumenter og annen relevant informasjon om oss.

Besøk vårt presserom